First Time Loading...

Winning Health Technology Group Co Ltd
SZSE:300253

Watchlist Manager
Winning Health Technology Group Co Ltd Logo
Winning Health Technology Group Co Ltd
SZSE:300253
Watchlist
Price: 6.59 CNY -2.95% Market Closed
Updated: May 13, 2024
Section:
 

Relative Value

The Relative Value of one Winning Health Technology Group Co Ltd stock under the Base Case scenario is 11.96 CNY. Compared to the current market price of 6.59 CNY, Winning Health Technology Group Co Ltd is Undervalued by 45%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
11.96 CNY
Undervaluation 45%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.4
P/S
P/S
Price to Sales
4.4
vs History
96
vs Industry
30
Median 3Y
7
Median 5Y
12.3
Industry
2.4
Forward
3.4
More Details
32.2
P/E
P/E
Price to Earnings
32.2
vs History
98
vs Industry
18
Median 3Y
65.2
Median 5Y
70.8
Industry
23.9
Forward
25.3
More Details
83.9
P/OCF
P/OCF
Price to OCF
83.9
vs History
71
vs Industry
3
Median 3Y
88.1
Median 5Y
116
Industry
15.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-68.1
Median 5Y
18.6
Industry
22.5
More Details
2.5
P/B
P/B
Price to Book Value
2.5
vs History
96
vs Industry
36
Median 3Y
4.1
Median 5Y
6.4
Industry
2.3
More Details
4.5
EV/S
EV/S
Enterprise Value to Sales
4.5
vs History
96
vs Industry
28
Median 3Y
7
Median 5Y
12.3
Industry
2.5
Forward
3.5
More Details
10.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.1
vs History
96
vs Industry
22
Median 3Y
16.2
Median 5Y
23.3
Industry
5.3
More Details
27.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
27.7
vs History
98
vs Industry
11
Median 3Y
73.1
Median 5Y
73.1
Industry
12.9
Forward
21.1
More Details
27.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
27.7
vs History
98
vs Industry
17
Median 3Y
73.1
Median 5Y
73.1
Industry
17.8
Forward
25.6
More Details
85.3
EV/OCF
EV/OCF
Enterprise Value to OCF
85.3
vs History
69
vs Industry
3
Median 3Y
89.1
Median 5Y
115.7
Industry
15.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
103.3
Median 5Y
118.1
Industry
19.6
More Details
2.1
EV/IC
EV/IC
Enterprise Value to IC
2.1
vs History
96
vs Industry
37
Median 3Y
3.5
Median 5Y
5.6
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
Winning Health Technology Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Winning Health Technology Group Co Ltd
SZSE:300253
14.1B CNY 4.4 32.2 27.7 27.7
US
Veeva Systems Inc
NYSE:VEEV
32.9B USD 13.9 62.5 62.4 67.2
US
Cerner Corp
NASDAQ:CERN
27.9B USD 4.8 47.3 19.6 38.6
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD 2.6 -116.8 16.5 111.6
AU
Pro Medicus Ltd
ASX:PME
12B AUD 82.3 172.5 118.7 118.7
JP
M3 Inc
TSE:2413
1.1T JPY 4.7 23.8 12.3 13.9
US
Inspire Medical Systems Inc
NYSE:INSP
5B USD 7.5 -316.4 -137.9 -126
US
Doximity Inc
NYSE:DOCS
4.4B USD 9.3 31.6 21 22.4
SE
Sectra AB
STO:SECT B
45.4B SEK 27.7 107 -70.5 -70.5
US
Evolent Health Inc
NYSE:EVH
2.8B USD 1.4 -19.6 23.4 249.3
US
Vocera Communications Inc
NYSE:VCRA
2.8B USD 11.7 -324 264.4 4 233.4
P/E Multiple
Earnings Growth
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Average P/E: 68.1
32.2
100%
US
Veeva Systems Inc
NYSE:VEEV
62.5
139%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
AU
Pro Medicus Ltd
ASX:PME
172.5
119%
JP
M3 Inc
TSE:2413
23.8
26%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -316.4 N/A
US
Doximity Inc
NYSE:DOCS
31.6
79%
SE
Sectra AB
STO:SECT B
107
56%
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -19.6 N/A
US
Vocera Communications Inc
NYSE:VCRA
Negative Multiple: -324 N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.